Breast Imaging Market Analysis Overview:
The Breast Imaging Market is projected to grow at a significant pace reaching a CAGR of approximately 8.17%, over the forecast period of 2022–2028, despite a considerable fall in product sales during the initial phase of pandemic spread and lockdown restrictions imposed globally.
In a recent research report by Market Research Community, the breast imaging market is expected to surpass USD 9.47 Billion by the year 2030, from USD 4.67 Billion in 2021.
Breast cancer is one of the most common cancer in developing ecAn aging female population, increasing investment and funding in RD for breast cancer treatment, rising incidence and prevalence of breast cancer, growing public awareness of the importance of early detection of breast cancer and other related diseases, technological advancements and the introduction of advanced breast imaging equipment and software, and technological innovations all contribute to the growth of the breast imaging market and market opportunities.
An aging female population, increasing investment and funding in RD for breast cancer treatment, rising incidence and prevalence of breast cancer, growing public awareness of the importance of early detection of breast cancer and other related diseases, technological advancements, and the introduction of advanced breast imaging equipment and software, and technological innovations all contribute to the growth of the breast imaging market and market opportunities.
Top Key Players of the Breast Imaging Market:
Hologic, Inc., GE Healthcare, Canon Inc., Siemens AG, Koninklijke Philips N.V., Carestream Health, Inc, Planmed Oy, Hitachi, Ltd., Dilon Technologies Inc., CMR Naviscan Corporation, FUJIFILM Holdings Corporation, Aurora Healthcare US Corp, SonoCine Inc.
Regional Analysis:
North America– (U.S., Canada, Mexico)
Europe- (Germany, France, U.K., Russia, Italy, Spain, BENELUX, Rest of Europe)
Asia Pacific- (China, Japan, India, South Korea, Australia, ASEAN, Rest of Asia Pacific)
Latin America- (Brazil, Argentina, Chile, Rest of Latin America)
Middle East and Africa- (GCC, Turkey, Israel, Rest of MEA)
By End User:
Hospitals, Diagnostic Imaging Centers, Ambulatory Surgical Centers
The study is consolidated into major segments and further into sub-segments, such as by Technology (Ionizing Technology, Non-Ionizing Technology), breast imaging market outlook, by end-use (Hospitals, Diagnostic Imaging Centers, Ambulatory Surgical Centers) to forecast the market size by value; also includes the analysis of past market dynamics from 2016 – 2021, considering 2021 as the base year.
The research provides answers to the following key questions:
- What type of customers buying the products and services from companies operating in the Breast Imaging Market?
- What will be the roadmap for the product manufacturers operating in the Breast Imaging industry for the forecast period, 2022 to 2030?
- What are the recent developments in the competitive landscape to look out for during the estimated period?
- What are the major trends influencing customers’ lives and their buying behaviour?
- How can brands best communicate with the customers they intend to target?
- When, where and how the customers want to use or consume the products or services?
Contact:
